You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0521 Differences in disease characteristics of patients with active psoriatic arthritis prior to adalimumab treatment who failed at least two antitnf-therapies in comparison to those who failed conventional dmards only

Article metrics

Article menu
Download PDFPDF
Abstracts accepted for publication
Spondyloarthritis - treatment
AB0521 Differences in disease characteristics of patients with active psoriatic arthritis prior to adalimumab treatment who failed at least two antitnf-therapies in comparison to those who failed conventional dmards only

 

Online download statistics by month:

Online download statistics by month: February 2014 to February 2024

AbstractFullPdf
Feb 2014300
Mar 2014700
Apr 2014700
May 2014300
Jul 2014100
Aug 20141601
Sep 2014400
Oct 2014301
Nov 2014202
Dec 2014601
Jan 2015100
Feb 2015700
Mar 2015401
Apr 2015503
May 2015100
Jun 2015200
Jul 2015300
Aug 2015200
Sep 2015300
Oct 2015100
Nov 2015202
Dec 2015201
Jan 20161000
Feb 2016400
Mar 2016200
Apr 2016100
May 2016300
Jun 2016100
Jul 2016400
Aug 2016400
Sep 2016300
Oct 2016600
Nov 2016400
Dec 20161200
Jan 2017400
Feb 2017100
Mar 2017500
Apr 2017500
May 20171701
Jun 2017100
Jul 20171200
Aug 20172601
Sep 20171400
Oct 2017800
Nov 2017200
Dec 2017800
Jan 2018800
Feb 2018400
Mar 20181602
Apr 2018600
May 20182001
Jun 20181402
Aug 20181000
Sep 2018800
Oct 20181001
Nov 2018200
Feb 2019600
Mar 2019200
Apr 2019200
Oct 2019200
Feb 2020200
Apr 2020200
Jun 2020300
Jul 2020200
Sep 20201000
Oct 2020400
Nov 2020200
Dec 2020400
Jan 2021200
Feb 2021200
May 2021400
Oct 2021200
Nov 2021400
Dec 20211000
Jan 2022200
Feb 2022200
Apr 2022200
May 2022200
Jul 20221600
Aug 2022801
Sep 2022600
Oct 2022200
Nov 2022400
Dec 2022600
Jan 20233400
Feb 2023200
Mar 2023400
May 2023400
Jul 2023200
Aug 2023400
Sep 2023600
Oct 2023400
Dec 2023600
Feb 20241600
Total537021